{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:57:15Z","timestamp":1757613435041,"version":"3.44.0"},"reference-count":110,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780128204931"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/b978-0-12-820493-1.00025-8","type":"book-chapter","created":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T13:12:18Z","timestamp":1627045938000},"page":"33-48","source":"Crossref","is-referenced-by-count":0,"title":["The power of genomics, metabolomics, and other omics for target identification and validation"],"prefix":"10.1016","author":[{"given":"David M.","family":"Pereira","sequence":"first","affiliation":[]},{"given":"Jo\u00e3o C.","family":"Fernandes","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/cpt.911","article-title":"Clinical pharmacogenetics implementation consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update","volume":"103","author":"Amstutz","year":"2018","journal-title":"Clin. Pharmacol. Therap."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib2","article-title":"Current status of hepatocellular carcinoma detection: screening strategies and novel biomarkers","volume":"11","author":"Ayoub","year":"2019","journal-title":"Therap. Adv. Med. Oncol."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.5858\/arpa.2014-0250-CP","article-title":"College of American Pathologists' laboratory standards for next-generation sequencing clinical tests","volume":"139","author":"Aziz","year":"2015","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev-physchem-040412-110026","article-title":"Chemical aspects of the extractive methods of ambient ionization mass spectrometry","volume":"64","author":"Badu-Tawiah","year":"2013","journal-title":"Annu. Rev. Phys. Chem."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib5","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1039\/C5MB00158G","article-title":"Metabolomics\u2013the complementary field in systems biology: a review on obesity and type 2 diabetes","volume":"11","author":"Bakar","year":"2015","journal-title":"Mol. Biosyst."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3390\/molecules21030259","article-title":"Statistical correlations between HPLC activity-based profiling results and NMR\/MS microfraction data to deconvolute bioactive compounds in mixtures","volume":"21","author":"Bertrand","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/j.seminoncol.2017.02.008","article-title":"Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: assessment of a multiparametric approach","volume":"44","author":"Boisdron-Celle","year":"2017","journal-title":"Semin. Oncol."},{"issue":"22.1","key":"10.1016\/B978-0-12-820493-1.00025-8_bib8","article-title":"Overview of DNA microarrays: types, applications, and their future","volume":"101","author":"Bumgarner","year":"2013","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/0929867324666170914102236","article-title":"Current trends in cancer biomarker discovery using urinary metabolomics: achievements and new challenges","volume":"26","author":"Burton","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for Publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin. Chem."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib11","doi-asserted-by":"crossref","first-page":"7687851","DOI":"10.1155\/2017\/7687851","article-title":"Metabolic footprints and molecular subtypes in breast cancer","volume":"2017","author":"Cappelletti","year":"2017","journal-title":"Dis. Markers"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib12","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa1602253","article-title":"70-gene signature as an aid to treatment decisions in early-stage breast cancer","volume":"375","author":"Cardoso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib101","first-page":"305","article-title":"DNA polymerases drive DNA sequencing-by-synthesis technologies: Both past and present","volume":"5","author":"Chen","year":"2014","journal-title":"Evolut Gen Microbiol"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/cpt.1664","article-title":"Global pharmacogenomics within precision medicine: challenges and opportunities","volume":"107","author":"Chenoweth","year":"2020","journal-title":"Clin. Pharmacol. Therap."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib14","article-title":"In silico drug repurposing to combat covid-19 based on pharmacogenomics of patient transcriptomic data","author":"Das","year":"2020","journal-title":"Res. Sq"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/genes10040261","article-title":"Pharmacogenetics in the treatment of cardiovascular diseases and its current progress regarding implementation in the clinical routine","volume":"10","author":"D\u00e1vila-Fajardo","year":"2019","journal-title":"Genes"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11306-018-1347-7","article-title":"NormalizeMets: assessing, selecting and implementing statistical methods for normalizing metabolomics data","volume":"14","author":"De Livera","year":"2018","journal-title":"Metabolomics"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib17","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.dld.2018.08.019","article-title":"Novel biomarkers in hepatocellular carcinoma","volume":"50","author":"De Stefano","year":"2018","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib18","first-page":"4","article-title":"Next-generation sequencing approach for the diagnosis of human diseases: open challenges and new opportunities","volume":"29","author":"Di Resta","year":"2018","journal-title":"J. Int. Federation Clin. Chem. Lab. Med."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41585-019-0185-3","article-title":"Cancer metabolomic markers in urine: evidence, techniques and recommendations","volume":"16","author":"Dinges","year":"2019","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib20","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00216-014-7646-6","article-title":"Recent methodological advances in MALDI mass spectrometry","volume":"406","author":"Dreisewerd","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/metabo9070123","article-title":"NMR spectroscopy for metabolomics research","volume":"9","author":"Emwas","year":"2019","journal-title":"Metabolites"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11306-016-1058-x","article-title":"LC\u2013MS based global metabolite profiling: the necessity of high data quality","volume":"12","author":"Engskog","year":"2016","journal-title":"Metabolomics"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib23","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/rcm.4454","article-title":"First report of non-coloured flavonoids in Echium plantagineum bee pollen: differentiation of isomers by liquid chromatography\/ion trap mass spectrometry","volume":"24","author":"Ferreres","year":"2010","journal-title":"Rapid Commun. Mass. Spectrometry"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib102","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/81137","article-title":"Metabolite profiling for plant functional genomics","volume":"18","author":"Fiehn","year":"2000","journal-title":"Nat Biotechnol"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib24","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2217\/bmm-2017-0449","article-title":"Identification of serum biomarkers of chemoradiosensitivity in esophageal cancer via the targeted metabolomics approach","volume":"12","author":"Fujigaki","year":"2018","journal-title":"Biomarkers Med."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib25","first-page":"256","article-title":"Cancer biomarker discovery and validation","volume":"4","author":"Goossens","year":"2015","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib26","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/14789450.2018.1505510","article-title":"Applications of MALDI-TOF mass spectrometry in clinical proteomics","volume":"15","author":"Greco","year":"2018","journal-title":"Expert. Rev. Proteom."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.lungcan.2010.12.008","article-title":"Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: review of the evidence","volume":"71","author":"Gridelli","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib28","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2147\/CMAR.S156837","article-title":"Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation","volume":"11","author":"Guo","year":"2018","journal-title":"Cancer Manage. Res."},{"year":"2019","series-title":"Biomarkers in Toxicology","author":"Gupta","key":"10.1016\/B978-0-12-820493-1.00025-8_bib29"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib30","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10549-016-3956-z","article-title":"Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH","volume":"159","author":"Hackmann","year":"2016","journal-title":"Breast Cancer Res. Treatment"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/jnnp-2014-309676","article-title":"Identification of novel biomarkers for Parkinson's disease by metabolomic technologies","volume":"87","author":"Hatano","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cca.2017.02.011","article-title":"Identification of highly sensitive biomarkers that can aid the early detection of pancreatic cancer using GC\/MS\/MS-based targeted metabolomics","volume":"468","author":"Hirata","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2164-12-598","article-title":"Sequencing by ligation variation with endonuclease V digestion and deoxyinosine-containing query oligonucleotides","volume":"12","author":"Ho","year":"2011","journal-title":"BMC Genom."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.20892\/j.issn.2095-3941.2019.0348","article-title":"A systematic review of metabolomic profiling of gastric cancer and esophageal cancer","volume":"17","author":"Huang","year":"2020","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib35","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.4155\/bio-2018-0135","article-title":"Next-generation biomarker discovery in Alzheimer's disease using metabolomics\u2013from animal to human studies","volume":"10","author":"Hurtado","year":"2018","journal-title":"Bioanalysis"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13062-015-0077-2","article-title":"Microarray experiments and factors which affect their reliability","volume":"10","author":"Jaksik","year":"2015","journal-title":"Biol. Direct"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib37","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1440-1681.2006.04398.x","article-title":"DNA microarray technology for target identification and validation","volume":"33","author":"Jayapal","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib38","first-page":"59","article-title":"Personalized medicine in breast cancer: pharmacogenomics approaches","volume":"12","author":"Jeibouei","year":"2019","journal-title":"Pharmacogenom. Pers. Med."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib39","series-title":"Antidepressants","article-title":"Pharmacogenomics and biomarkers of depression","author":"Jha","year":"2018"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib103","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nm0413-381","article-title":"Competition intensifies over DNA-based tests for prenatal diagnoses","volume":"19","author":"Jiang","year":"2013","journal-title":"Nature Med"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib41","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1124\/pr.112.007252","article-title":"Pharmacogenetics and cardiovascular disease\u2014implications for personalized medicine","volume":"65","author":"Johnson","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib40","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrm.2016.25","article-title":"Metabolomics: beyond biomarkers and towards mechanisms","volume":"17","author":"Johnson","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib42","doi-asserted-by":"crossref","DOI":"10.4172\/0974-8369.1000395","article-title":"Generations of sequencing technologies: from first to next generation","volume":"9","author":"Kchouk","year":"2017","journal-title":"Biol. Med."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib43","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.ejps.2017.05.018","article-title":"Integrating clinical metabolomics-based biomarker discovery and clinical pharmacology to enable precision medicine","volume":"109","author":"Kohler","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib44","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/jxb\/eri010","article-title":"Metabolite fingerprinting and profiling in plants using NMR","volume":"56","author":"Krishnan","year":"2005","journal-title":"J. Exp. Botany"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib45","doi-asserted-by":"crossref","DOI":"10.2217\/pgs-2020-0011","article-title":"Precision in cancer pharmacogenomics","volume":"21","author":"Kyrochristos","year":"2020","journal-title":"Pharmacogenomics"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib46","series-title":"Pharmacogenomics","article-title":"The role of pharmacogenomics in diabetes","author":"Lam","year":"2019"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1021\/ac504075g","article-title":"NMR spectroscopy for metabolomics and metabolic profiling","volume":"87","author":"Larive","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib48","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.4155\/bio-2019-0145","article-title":"Plasma\/serum proteomics: depletion strategies for reducing high-abundance proteins for biomarker discovery","volume":"11","author":"Lee","year":"2019","journal-title":"Bioanalysis"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-genom-083115-022413","article-title":"Advancements in next-generation sequencing","volume":"17","author":"Levy","year":"2016","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib50","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s00216-019-01600-z","article-title":"Statistically correlating NMR spectra and LC-MS data to facilitate the identification of individual metabolites in metabolomics mixtures","volume":"411","author":"Li","year":"2019","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib51","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1039\/C7RA13616A","article-title":"Metabolomic estimation of the diagnosis of hepatocellular carcinoma based on ultrahigh performance liquid chromatography coupled with time-of-flight mass spectrometry","volume":"8","author":"Li","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib52","series-title":"Genomic and Precision Medicine","article-title":"HIV pharmacogenetics and pharmacogenomics: from bench to bedside","author":"Limou","year":"2019"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib53","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.tibs.2017.01.004","article-title":"Metabolomics: a primer","volume":"42","author":"Liu","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib104","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1134\/S1990750810010051","article-title":"Metabolic fingerprinting of blood plasma from patients with prostate cancer","volume":"4","author":"Lokhov","year":"2010","journal-title":"Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib54","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41397-019-0102-4","article-title":"Pharmacogenomics, biomarker network, and allele frequencies in colorectal cancer","volume":"20","author":"L\u00f3pez-Cort\u00e9s","year":"2020","journal-title":"Pharmacogenom. J."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib55","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41436-019-0646-3","article-title":"The Genomics Research and Innovation Network: creating an interoperable, federated, genomics learning system","volume":"22","author":"Mandl","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nprot.2016.182","article-title":"DNA sequencing technologies: 2006\u20132016","volume":"12","author":"Mardis","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib57","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.copbio.2016.08.001","article-title":"The future of NMR-based metabolomics","volume":"43","author":"Markley","year":"2017","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib58","doi-asserted-by":"crossref","first-page":"68899","DOI":"10.18632\/oncotarget.20324","article-title":"Metabolomic biomarkers of pancreatic cancer: a meta-analysis study","volume":"8","author":"Mehta","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cels.2020.05.012","article-title":"Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection","volume":"11","author":"Messner","year":"2020","journal-title":"Cell Syst."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrg2626","article-title":"Sequencing technologies\u2014the next generation","volume":"11","author":"Metzker","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib61","series-title":"Advances in Cancer Biomarkers","article-title":"Cancer biomarkers discovery and validation: state of the art, problems and future perspectives","author":"Mordente","year":"2015"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib62","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.drudis.2016.11.020","article-title":"UPLC\u2013MS for metabolomics: a giant step forward in support of pharmaceutical research","volume":"22","author":"Nassar","year":"2017","journal-title":"Drug Discovery Today"},{"year":"2008","series-title":"Lehninger Principles of Biochemistry","author":"Nelson","key":"10.1016\/B978-0-12-820493-1.00025-8_bib63"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib64","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3390\/microarrays3040245","article-title":"Particle-based microarrays of oligonucleotides and oligopeptides","volume":"3","author":"Nesterov-Mueller","year":"2014","journal-title":"Microarrays"},{"issue":"825-832","key":"10.1016\/B978-0-12-820493-1.00025-8_bib106","first-page":"837","article-title":"Down syndrome: prenatal risk assessment and diagnosis","volume":"62","author":"Newberger","year":"2000","journal-title":"Am Fam Physician"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib65","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cmet.2016.09.018","article-title":"Metabolomics and metabolic diseases: where do we stand?","volume":"25","author":"Newgard","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib105","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/004982599238047","article-title":"'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data","volume":"29","author":"Nicholson","year":"1999","journal-title":"Xenobiotica"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib66","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv015","article-title":"Breast cancer genomics from microarrays to massively parallel sequencing: paradigms and new insights","volume":"107","author":"Ng","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib67","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/cas.12650","article-title":"Cancer immunotherapy using novel tumor-associated antigenic peptides identified by genome-wide cDNA microarray analyses","volume":"106","author":"Nishimura","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib68","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1007\/s00216-020-02807-1","article-title":"Nuclear magnetic resonance and surface-assisted laser desorption\/ionization mass spectrometry-based serum metabolomics of kidney cancer","volume":"412","author":"Nizio\u0142","year":"2020","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib107","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0167-7799(98)01214-1","article-title":"Systematic functional analysis of the yeast genome","volume":"16","author":"Oliver","year":"1998","journal-title":"Trends Biotechnol"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib69","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/07853890.2015.1137630","article-title":"Metabolomics in diabetes, a review","volume":"48","author":"Pallares-Mendez","year":"2016","journal-title":"Ann. Med."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib70","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/cpt.1484","article-title":"Diabetes: is there a future for pharmacogenomics guided treatment?","volume":"106","author":"Pearson","year":"2019","journal-title":"Clin. Pharmacol. Therap."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib71","series-title":"OMICS: Biomedical Perspectives and Applications","article-title":"Marine metabolomics in cancer chemotherapy","author":"Pereira","year":"2012"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib72","unstructured":"Pereira, D., Valent\u00e3o, P., Ferreres, F. Andrade, P. 2010. Metabolomic analysis of natural products. In: Reviews in Pharmaceutical and Biomedical Analysis, Bentham Science."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib73","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3390\/nu11051092","article-title":"Biomarkers of nutrition and health: new tools for new approaches","volume":"11","author":"Pic\u00f3","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib74","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/jn\/nxy053","article-title":"Metabolic footprinting of fermented milk consumption in serum of healthy men","volume":"148","author":"Pimentel","year":"2018","journal-title":"J. Nutrition"},{"issue":"1","key":"10.1016\/B978-0-12-820493-1.00025-8_bib108","first-page":"96","article-title":"Eukaryotic genome complexity","volume":"1","author":"Pray","year":"2008","journal-title":"Nature Education"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib75","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/bmb\/ldr029","article-title":"Next generation sequencing\u2014implications for clinical practice","volume":"99","author":"Raffan","year":"2011","journal-title":"Brit. Med. Bull."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib76","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.atherosclerosis.2012.10.078","article-title":"A comparison of the accuracy of Illumina HumanHT-12 v3 Expression BeadChip and TaqMan qRT-PCR gene expression results in patient samples from the Tampere Vascular Study","volume":"226","author":"Raitoharju","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib77","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature15817","article-title":"Pharmacogenomics in the clinic","volume":"526","author":"Relling","year":"2015","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib78","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nature23306","article-title":"Integrative clinical genomics of metastatic cancer","volume":"548","author":"Robinson","year":"2017","journal-title":"Nature"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib79","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10637-014-0192-4","article-title":"Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-\u03b2 receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer","volume":"33","author":"Rod\u00f3n","year":"2015","journal-title":"Investig. N. Drugs"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib80","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.3390\/ijms21134709","article-title":"Pharmacogenomics of hypertension treatment","volume":"21","author":"Rysz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib81","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1586\/14737159.2015.1105133","article-title":"Transcriptomics in cancer diagnostics: developments in technology, clinical research and commercialization","volume":"15","author":"Sager","year":"2015","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib109","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1073\/pnas.74.12.5463","article-title":"DNA sequencing with chain-terminating inhibitors","volume":"74","author":"Sanger","year":"1977","journal-title":"P Natl Acad Sci USA"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib82","doi-asserted-by":"crossref","first-page":"E190","DOI":"10.1038\/35087138","article-title":"Navigating gene expression using microarrays\u2014a technology review","volume":"3","author":"Schulze","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib83","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-018-0304-2","article-title":"Recent advances and perspectives of metabolomics-based investigations in Parkinson\u2019s disease","volume":"14","author":"Shao","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib84","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00280-019-03936-w","article-title":"Dihydropyrimidine dehydrogenase in the metabolism of the anticancer drugs","volume":"84","author":"Sharma","year":"2019","journal-title":"Cancer Chemotherapy Pharmacol."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib85","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.2174\/1389557516666160321114917","article-title":"Review on EGFR inhibitors: critical updates","volume":"16","author":"Singh","year":"2016","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-020-03208-7","article-title":"Biomarkers in critical care nutrition","volume":"24","author":"Stoppe","year":"2020","journal-title":"Crit. Care"},{"year":"2017","series-title":"Metabolomics: From Fundamentals to Clinical Applications","author":"Sussulini","key":"10.1016\/B978-0-12-820493-1.00025-8_bib87"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib110","doi-asserted-by":"crossref","first-page":"M111","DOI":"10.1074\/mcp.M111.010694","article-title":"Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: potential biomarkers effective for small hepatocellular carcinoma diagnosis","volume":"11","author":"Tan","year":"2012","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41525-020-00143-y","article-title":"Pharmacogenomics of COVID-19 therapies","volume":"5","author":"Takahashi","year":"2020","journal-title":"NPJ Genom. Med."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib89","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.tibtech.2018.12.002","article-title":"The ultimate qPCR experiment: producing publication quality, reproducible data the first time","volume":"37","author":"Taylor","year":"2019","journal-title":"Trends Biotechnol."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib90","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/ejhg.2014.126","article-title":"Parents\u2019 responses to receiving sickle cell or cystic fibrosis carrier results for their child following newborn screening","volume":"23","author":"Ulph","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib91","series-title":"Molecular Profiling","article-title":"Serum low-molecular-weight protein fractionation for biomarker discovery","author":"Vanmeter","year":"2012"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib111","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1021\/pr2009252","article-title":"Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography\u2013mass spectrometry","volume":"11","author":"Wang","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib92","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jpha.2016.03.006","article-title":"Comparison of ESI\u2013and APCI\u2013LC\u2013MS\/MS methods: a case study of levonorgestrel in human plasma","volume":"6","author":"Wang","year":"2016","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib93","series-title":"Mayo Clinic Proceedings","first-page":"1711","article-title":"Pharmacogenomics: precision medicine and drug response","author":"Weinshilboum","year":"2017"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib94","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrd.2016.32","article-title":"Emerging applications of metabolomics in drug discovery and precision medicine","volume":"15","author":"Wishart","year":"2016","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib95","article-title":"Pharmacogenomics of antiretroviral drug metabolism and transport","volume":"61","author":"Yu","year":"2020","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib96","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/metabo8030047","article-title":"Statistical analysis of NMR metabolic fingerprints: established methods and recent advances","volume":"8","author":"Zacharias","year":"2018","journal-title":"Metabolites"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/metabo7010001","article-title":"Fully automated trimethylsilyl (TMS) derivatisation protocol for metabolite profiling by GC-MS","volume":"7","author":"Zarate","year":"2017","journal-title":"Metabolites"},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib98","doi-asserted-by":"crossref","first-page":"14966","DOI":"10.1039\/C6RA28715H","article-title":"Emerging role and recent applications of metabolomics biomarkers in obesity disease research","volume":"7","author":"Zhang","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/B978-0-12-820493-1.00025-8_bib99","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bbrc.2017.07.060","article-title":"Metabolomic profiling reveals potential biomarkers in esophageal cancer progression using liquid chromatography-mass spectrometry platform","volume":"491","author":"Zhang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Principles of Translational Science in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128204931000258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128204931000258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T20:09:41Z","timestamp":1757016581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128204931000258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780128204931"],"references-count":110,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-820493-1.00025-8","relation":{},"subject":[],"published":{"date-parts":[[2021]]}}}